Get the Stockscreener App
1.2799
9.48%
0.1199
Glucotrack Inc stock is traded at $1.2799, with a volume of 3.29M.
It is up +9.48% in the last 24 hours and down -41.16% over the past month.
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.
See More
Previous Close:
$1.16
Open:
$1.21
24h Volume:
3.29M
Relative Volume:
58.66
Market Cap:
$6.93M
Revenue:
-
Net Income/Loss:
$-8.74M
P/E Ratio:
-3.9997
EPS:
-0.32
Net Cash Flow:
$-8.25M
1W Performance:
-28.65%
1M Performance:
-41.16%
6M Performance:
-58.36%
1Y Performance:
+44.98%
1-Day Range:
$1.15
$2.44
1-Week Range:
$1.085
$2.44
52-Week Range:
$0.664
$4.95
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Glucotrack Inc Stock (GCTK) Latest News
GlucoTrack (NASDAQ:GCTK) to Present Continuous Blood Glucose Monitor at 2024 BioFuture Meeting** - Defense World
Say Goodbye To Finger Pricks! Glucotrack($GCTK)’s Long-Lasting Glucose Monitor Is Here - MSN
GCTKGlucoTrack, Inc. Latest Stock News & Market Updates - StockTitan
GlucoTrack to Unveil Implantable Glucose Monitor at BioFuture - TipRanks
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE - The Manila Times
GCTK Stock Earnings: GlucoTrack Reported Results for Q1 2024 - MSN
GlucoTrack (NASDAQ:GCTK) Stock Price Down 1.4% – Here’s What Happened - Defense World
Expanding Continuous Glucose Monitoring Options: How Glucotrack Is Helping Usher In The Next Generation Of Diabetes Care Technology - Nasdaq
GlucoTrack Showcases Innovations at Diabetes Tech Meeting - TipRanks
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING - EIN News
Glucotrack shareholders approve pivotal issuance proposal - Investing.com India
Glucotrack shareholders approve pivotal issuance proposal By Investing.com - Investing.com Canada
Hand-held Glucose Meter Market Growth Ourlook – OrbisResearch - Economica
Godolphin Resources Unveils Comprehensive 2024 Annual Report - TipRanks
Globavend Holdings Limited Announces First Half 2024 Unaudited Financial Results - GlobeNewswire
Global Petroleum Expands Australian Exploration - TipRanks
Qwic owner EcoMotion saves cycling gear brand AGU from downfall - Bike Europe
GPT Infraprojects Secures ₹204 Crore Railway Contract - Indiainfoline
Local Winter Classic competitors clash again in SA Oaks final - The Border Watch
Greenlane to distribute new drug detection strips - Investing.com
GyC hits Kenya, South Africa, Mozambique for mega tour - Guardian Nigeria
Glucotrack Appoints Andy Balo To Its Board Of Directors - MPO-mag
Glucotrack appoints biotech veteran to board amid expansion By Investing.com - Investing.com Canada
Glucotrack appoints biotech veteran to board amid expansion - Investing.com
GlucoTrack appoints John Ballantyne to board of directors - TipRanks
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS - StockTitan
Glucotrack Wins New Funding For Continuous Blood Glucose Monitor - MPO-mag
Glucotrack Wins New Funding for Continuous Blood Glucose Monitor - MPO-mag
Head-To-Head Analysis: GlucoTrack (NASDAQ:GCTK) vs. Tactile Systems Technology (NASDAQ:TCMD) - Defense World
Glucotrack appoints new VP for clinical trials - Investing.com India
GlucoTrack Welcomes New VP of Clinical Operations - TipRanks
GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS - StockTitan
Glucotrack's Innovative Continuous Blood Glucose Monitor Aims to Revolutionize Diabetes Management - Vancity Buzz
Poster Presentations, Upcoming Human Trials, Recently Secured Fu - News Channel Nebraska
GCTK Stock Earnings: GlucoTrack Reported Results for Q2 2024 - MSN
Glucotrack survey highlights interest in 3-year CBGM - Drug Delivery Business News
Glucotrack reveals positive feedback on new diabetes monitor - Investing.com
GlucoTrack Shares Market Research Insights Publicly - TipRanks
Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference - ForexTV.com
Glucotrack Appoints Andy Balo to its Board of Directors - MPO-mag
Glucotrack Augments Clinical Evidence for its Epidural Continuous Glucose Monitoring Tech - MPO-mag
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE - ForexTV.com
GlucoTrack (NASDAQ:GCTK) Stock Price Down 4.4% - Defense World
GlucoTrack eyes human trials for implantable blood glucose monitor - MSN
GlucoTrack Showcases Innovations at Industry Conference - TipRanks
GlucoTrack Secures $4M Funding and Expands Board Amid Reshuffle - TipRanks
GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR - StockTitan
GlucoTrack secures $4M funding from its leading shareholder for CBGM trial - TipRanks
BNP Paribas Financial Markets Decreases Stock Holdings in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):